The LDN Shop
Visit our e-commerce website for Conferences, Webinars, Medical Membership, eBooks etc
John Robinson, NMD - Thyroid Disease: Optimizing Metabolism Through Comprehensive Hormonal Treatment (2017 Conference) (LDN, low dose naltrexone)
Dr John Robinson begins this 80 minute presentation with a diagram showing the links between growth hormones, sex hormones and the thyroid gland. In turn, the diagram also demonstrates how these can have effects on sexuality, musculoskeletal function and immunity.
David Zava, PhD - Testing Steroid and Peptide Hormones (2017 Conference) (LDN, low dose naltrexone)
Plasma, urine, saliva, capillary blood are used for testing hormones. Steroid hormones are released from binding proteins, passively diffuse into tissues, and accumulate in the saliva. Pros of Dried Capillary Blood/ Dried Blood Spot (DBS) vs cons of the Venipuncture Serum collection system.
Mark Shukhman, MD - Sexual Function (2016 Conference) (LDN, low dose naltrexone)
Kent Holtorf, MD - Thyroid Disorders (2016 Conference) (LDN, low dose naltrexone)
Laurie Marzell, ND - LDN Case Studies (2017 Conference) (LDN, low dose naltrexone)
Dr Tara Thompson, 22nd July 2020 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.
Tara Thompson, PharmD shares her Low Dose Naltrexone (LDN) experience on the LDN Radio Show with Linda Elsegood.
Paul Anderson, NMD - Case Studies (2017 Conference) (LDN, low dose naltrexone)
The first case is an oncology patient, a 47 year old female with colorectal cancer. This lady presented herself while halfway through standard cancer treatment. Dr Anderson added many adjunct therapies as well as Low Dose Naltrexone and the patients tumour markers reduced for the first time.